Coriell Institute for Medical Research
Coriell Institute of Medical Research
  • Request a Quote
  • Donate
  • Login
  • View Cart
Sample Catalog | Custom Services | Core Facilities | Genomic Data Search
  • Biobank
    • NIGMS
    • NINDS
    • NIA
    • NHGRI
    • NEI
    • Allen Cell Collection
    • Rett Syndrome iPSC Collection
    • Autism Research Resource
    • HD Community Biorepository
    • CDC Cell and DNA
    • J. Craig Venter Institute
    • Orphan Disease Center Collection
    • All Biobanks
  • Research
    • Overview
    • Meet Our Scientists
      • Our Faculty
      • Our Scientific Staff
    • Camden Cancer Research Center
    • Epigenetic Therapies SPORE
    • Core Facilities
    • Epigenomics
    • Camden Opioid Research Initiative (CORI)
    • The Issa & Jelinek Lab
    • The Jian Huang Lab
    • The Luke Chen Lab
      • The Lab
      • The Team
      • Publications
    • The Scheinfeldt Lab
    • The Shumei Song Lab
    • The Nora Engel Lab
      • The Lab
      • The Team
      • Publications
    • Publications
  • Services
    • Overview
    • Biobanking Services
      • Core Services
      • Project Management
      • Research Support Services
      • Sample Cataloging
      • Sample Collection Kits
      • Sample Data Management
      • Sample Distribution
      • Sample Management
      • Sample Procurement
      • Sample Storage
    • Bioinformatics and Biostatistics Services
    • Cellular and Molecular Services
      • Biomarker Research Solutions
      • Cell Culture
      • Nucleic Acid Isolation and Quality Control
    • Clinical Trial Support
      • Overview
      • Sample Collection
      • Data Management
      • Sample Processing and QC
      • Storage and Distribution
      • Biomarker Services
      • Data Analaysis
    • Core Facilties
      • Overview
      • Animal and Xenograft
      • Bioinformatics and Biostatistics
      • Cell Imaging
      • CRISPR Gene Engineering
      • Flow Cytometry and Cell Sorting
      • Genomics and Epigenomics
      • iPSC - Induced Pluripotent Stem Cells
      • Organoids
    • Coriell Marketplace
    • Genomic, Epigenomic and Multiomics Services
    • Stem Cells and iPSC Services
      • Core Services
      • Reprogramming
      • Characterization and Quality Control
      • Differentiated Cell Lines
      • iPSC-Derived Organoids
      • iPSC Expansion
      • iPSC Gene Editing
  • Ordering
    • Stem Cells
    • Cell Lines
    • DNA and RNA
    • Featured Products
      • FFPE
      • HMW DNA
    • Genomic Data Search
    • Search by Catalog ID
    • Help
      • Create Account
      • Order Online
      • Ordering FAQ
      • FAQs/Culture Instructions
      • Reference Materials
        • Biobanks
        • NIGMS Repository
        • NHGRI Repository
        • NINDS Repository
        • NIA Repository
        • NIST
        • GeT-RM
      • Secondary Distribution Policies
      • MTA Assurance Form
      • Shipment Policy
      • Contact Customer Service
  • About Us
    • Our History
    • Meet Our Team
    • Meet Our Board
    • Education
      • Science Fair
      • Summer Experience
      • Outreach
      • Research Program Internship
    • Press Room
      • Press Releases
      • Coriell Blog
      • Annual Report
    • Careers
      • Working at Coriell
    • Giving
      • Donate
      • Giving FAQ
    • Contact Us
    • Legal Notice
  • Login View Cart
search submit
GM27386 Fibroblast

Description:

CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia
PHOSPHOMANNOMUTASE 2; PMM2

Affected:

Yes

Sex:

Female

Age:

5 YR (At Sampling)

  • Overview
  • Characterizations
  • Phenotypic Data
  • Publications
  • External Links
  • Culture Protocols

Overview

back to top
Repository NIGMS Human Genetic Cell Repository
Subcollection Heritable Diseases
PIGI Consented Sample
Cell Type Fibroblast
Tissue Type Skin
Transformant Untransformed
Race White
Ethnicity Not Hispanic/Latino
Ethnicity Scottish, German
Country of Origin USA
Family History N
Relation to Proband proband
Species Homo sapiens
Common Name Human
Remarks Clinically affected; diagnosed at 9 months of age; onset of symptoms at birth; born 38 weeks via C-section; mother had borderline gestational diabetes and two prior miscarriages; decreased fetal movement; torticollis at first week of life; axial hypotonia; tongue fasciculation; absent reflexes; areflexia; developmental delay; decreased deep tendon reflexes; patent foramen ovale; interrupted IVC with azygous return in right aortic arch with aberrant left subclavian; venous anomalies; muscle weakness; liver 1 cm below the costal margin; 2/6 systolic murmur; inverted nipples; mild head control; head lag; tapered fingers; positive stepping reflex; negative moro reflex; fontanel is fingertip in size; mild plagiocephaly noted; dysarthria; strabismus; difficulty chewing and or swallowing; severe central sleep apnea with mild hypoxemia; assistive devices include: wheelchair, orthotics; gene sequencing revealed two heterozygous pathogenic variants in the PMM2 gene on exon 5: c.415G>A(p.E139K) and c.422G>A(p.R141H); one variant was inherited from each parent; treatment and management include: physical therapy, occupational therapy, and speech therapy; family history: sister passed way early from truncus arteriosus, mother has a history of post-traumatic stress disorder (PTSD), father has history of anxiety and ADHD, paternal uncle was delivered prematurely and has developmental disabilities and cognitive impairment; no consanguinity; no other family members are in repository.

Characterizations

back to top
PDL at Freeze 9.53
Passage Frozen 2
 
IDENTIFICATION OF SPECIES OF ORIGIN Species of Origin Confirmed by LINE assay
 
Gene PMM2
Chromosomal Location 16p13.3-p13.2
Allelic Variant 1 ; CONGENITAL DISORDER OF GYLCOSYLATION, TYPE Ia
Identified Mutation c.415G>A (p.E139K)
 
Gene PMM2
Chromosomal Location 16p13.3-p13.2
Allelic Variant 1 601785.0001; CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia
Identified Mutation c.422G>A (p.R141H)

Phenotypic Data

back to top
Remarks Clinically affected; diagnosed at 9 months of age; onset of symptoms at birth; born 38 weeks via C-section; mother had borderline gestational diabetes and two prior miscarriages; decreased fetal movement; torticollis at first week of life; axial hypotonia; tongue fasciculation; absent reflexes; areflexia; developmental delay; decreased deep tendon reflexes; patent foramen ovale; interrupted IVC with azygous return in right aortic arch with aberrant left subclavian; venous anomalies; muscle weakness; liver 1 cm below the costal margin; 2/6 systolic murmur; inverted nipples; mild head control; head lag; tapered fingers; positive stepping reflex; negative moro reflex; fontanel is fingertip in size; mild plagiocephaly noted; dysarthria; strabismus; difficulty chewing and or swallowing; severe central sleep apnea with mild hypoxemia; assistive devices include: wheelchair, orthotics; gene sequencing revealed two heterozygous pathogenic variants in the PMM2 gene on exon 5: c.415G>A(p.E139K) and c.422G>A(p.R141H); one variant was inherited from each parent; treatment and management include: physical therapy, occupational therapy, and speech therapy; family history: sister passed way early from truncus arteriosus, mother has a history of post-traumatic stress disorder (PTSD), father has history of anxiety and ADHD, paternal uncle was delivered prematurely and has developmental disabilities and cognitive impairment; no consanguinity; no other family members are in repository.

Publications

back to top
Zhong M, Balakrishnan B, Guo AJ, Lai K, AAV9-based Molecular genetics and metabolism reports38:101035 2024
PubMed ID: 38130891

External Links

back to top
Gene Cards PMM2
Gene Ontology GO:0004615 phosphomannomutase activity
GO:0005737 cytoplasm
GO:0006487 N-linked glycosylation
GO:0008152 metabolism
GO:0009298 GDP-mannose biosynthesis
GO:0016853 isomerase activity
NCBI Gene Gene ID:5373
NCBI GTR 212065 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A
601785 PHOSPHOMANNOMUTASE 2; PMM2
OMIM 212065 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A
601785 PHOSPHOMANNOMUTASE 2; PMM2
Omim Description CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME, TYPE I; CDG1
  CARBOHYDRATE-DEFICIENT GLYCOPROTEIN SYNDROME, TYPE Ia; CDGS1A
  CDGS, TYPE I; CDGS1
  JAEKEN SYNDROME
  OPCA, NEONATAL, INCLUDED
  PHOSPHOMANNOMUTASE 2 DEFICIENCY
  PMM2 DEFICIENCYOLIVOPONTOCEREBELLAR ATROPHY, NEONATAL, INCLUDED

Culture Protocols

back to top
Cumulative PDL at Freeze 9.53
Passage Frozen 2
Split Ratio 1:4
Temperature 37 C
Percent CO2 5%
Percent O2 AMBIENT
Medium Eagle's Minimum Essential Medium with Earle's salts and non-essential amino acids with 2mM L-glutamine or equivalent
Serum 15% fetal bovine serum Not inactivated
Supplement -
Pricing
International/Commercial/For-profit:
$373.00USD
U.S. Academic/Non-profit/Government:
$216.00USD
Add to Cart
How to Order
  • Ordering Instructions
  • MTA / Assurance Form
  • Statement of Research Intent Form
Related Products
Miscellaneous
  • DNA on Demand
  • Custom Services

Our mission is to prevent and cure disease through biomedical research.

CONTACT US

CUSTOMER SERVICE
customerservice@coriell.org (800) 752-3805 • (856) 757-4848
Subscribe to our newsletter here

Coriell Institute for Medical Research
403 Haddon Avenue Camden, NJ 08103, USA (856) 966-7377

Ⓒ 2025 Coriell Institute. All rights reserved.

  • Facebook
  • Linkedin
  • Youtube